| Kaplan-Meier | Cox Regression Analysis |
---|
 | Significance | Significance | Exp(B) | CI |
---|
VCAMa
| Â | Â | Â | Â |
<1272 ng/ml | <0.001** | 0.001** | 1 | Â |
1272-1972 ng/ml | Â | Â | 1.7 | 0.83, 3.51 |
>1972 ng/ml | Â | Â | 3.3 | 1.7, 6.4 |
VCAMb
| Â | Â | Â | Â |
<1272 ng/ml | <0.001** | 0.030* | 1 | Â |
1272-1972 ng/ml | Â | Â | 1.5 | 0.73, 3.16 |
>1972 ng/ml | Â | Â | 2.4 | 1.21, 4.81 |
VCAMc
| Â | Â | Â | Â |
<1272 ng/ml | <0.001** | 0.049* | 1 | Â |
1272-1972 ng/ml | Â | Â | 1.4 | 0.6, 2.9 |
>1972 ng/ml | Â | Â | 2.2 | 1.1, 4.5 |
- Levels of significance (* p < 0.05, ** p < 0.01).
-
aCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol and HDL cholesterol.
-
bCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, eGFR and hsCRP.
-
cCox Regression analysis adjusted for age, gender, smoking, diabetes, systolic blood pressure, total cholesterol, HDL cholesterol, eGFR, hsCRP and history of vascular disease at enrolment